PAPER Adeniyi AA, Conradie J

Computational insight into the anticholinesterase activities and electronic properties of physostigmine analogs.

Future Med Chem. 2019 Aug;11(15):1907-1928. PubMed: 31517530

PAPER Durant J, Berg JL, Banks SJ, Kaylegian J, Miller JB

Comparing the Boston Naming Test With the Neuropsychological Assessment Battery-Naming Subtest in a Neurodegenerative Disease Clinic Population.

Assessment. 2019 Sep 13;:1073191119872253. PubMed: 31516023

PAPER Harris AR, McGivern P, Ooi L

Modeling Emergent Properties in the Brain Using Tissue Models to Investigate Neurodegenerative Disease.

Neuroscientist. 2019 Sep 13;:1073858419870446. PubMed: 31517587

PAPER Domingos S, Duarte T, Saraiva L, Guedes RC, Moreira R

Targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of Parkinson's disease.

Future Med Chem. 2019 Aug;11(15):1953-1977. PubMed: 31517532

PAPER Gonçalves AC, Marques A, Samuel D, Demain S

Outcomes of physical activity for people living with dementia: qualitative study to inform a Core Outcome Set.

Physiotherapy. 2019 Jun 2; PubMed: 31515072

PAPER Walton CC, Lampit A, Boulamatsis C, Hallock H, Barr P, Ginige JA, Brodaty H, Chau T, Heffernan M, Sachdev PS, Fiatarone Singh MA, Valenzuela M

Design and Development of the Brain Training System for the Digital "Maintain Your Brain" Dementia Prevention Trial.

JMIR Aging. 2019 Feb 27;2(1):e13135. PubMed: 31518277

PAPER Guisado-Fernández E, Giunti G, Mackey LM, Blake C, Caulfield BM

Factors Influencing the Adoption of Smart Health Technologies for People With Dementia and Their Informal Caregivers: Scoping Review and Design Framework.

JMIR Aging. 2019 Apr 30;2(1):e12192. PubMed: 31518262

PAPER

Correction: Cognitive training and neuroplasticity in mild cognitive impairment (COG-IT): protocol for a two-site, blinded, randomised, controlled treatment trial.

BMJ Open. 2019 Sep 11;9(9):e028536corr1. PubMed: 31515436

PAPER Nakanishi M, Watanabe Y, Honda N, Une M, Kazuki K, Kazuki Y, Terashima T, Katagi M, Nakashima K, Hanajima R

Dynamics of host and graft after cell sheet transplantation: Basic study for the application of amyotrophic lateral sclerosis.

Brain Res. 2019 Dec 1;1724:146444. Epub 2019 Sep 10 PubMed: 31518575

PAPER Thomas B, Sheelakumari R, Kannath S, Sarma S, Menon RN

Regional Cerebral Blood Flow in the Posterior Cingulate and Precuneus and the Entorhinal Cortical Atrophy Score Differentiate Mild Cognitive Impairment and Dementia Due to Alzheimer Disease.

AJNR Am J Neuroradiol. 2019 Oct;40(10):1658-1664. Epub 2019 Sep 12 PubMed: 31515217

PAPER Mukhopadhyay A, Mehra S, Kumar R, Maji SK, Krishnamoorthy G, Sharma KP

α-Synuclein Spontaneously Adopts Stable and Reversible α-Helical Structure in Water-Less Environment.

Chemphyschem. 2019 Nov 5;20(21):2783-2790. Epub 2019 Oct 14 PubMed: 31515915

PAPER Vandoorne T, Veys K, Guo W, Sicart A, Vints K, Swijsen A, Moisse M, Eelen G, Gounko NV, Fumagalli L, Fazal R, Germeys C, Quaegebeur A, Fendt SM, Carmeliet P, Verfaillie C, Van Damme P, Ghesquière B, De Bock K, Van Den Bosch L

Differentiation but not ALS mutations in FUS rewires motor neuron metabolism.

Nat Commun. 2019 Sep 12;10(1):4147. PubMed: 31515480

PAPER Wang G, Aschenbrenner AJ, Li Y, McDade E, Liu L, Benzinger TL, Bateman RJ, Morris JC, Hassenstab JJ, Xiong C

Two-period linear mixed effects models to analyze clinical trials with run-in data when the primary outcome is continuous: Applications to Alzheimer's disease.

Alzheimers Dement (N Y). 2019;5:450-457. Epub 2019 Sep 5 PubMed: 31517032

PAPER Tian J, Shi J, Wei M, Ni J, Fang Z, Gao J, Wang H, Yao H, Zhang J, Li J, Min M, Su L, Sun X, Wang B, Wang B, Yang F, Zou Y, Hu Y, Lin Y, Xu G, Li K, Li L, Zhen H, Xu J, Chen K, Wang Y, CHARM study group

Chinese herbal medicine Qinggongshoutao for the treatment of amnestic mild cognitive impairment: A 52-week randomized controlled trial.

Alzheimers Dement (N Y). 2019;5:441-449. Epub 2019 Sep 4 PubMed: 31517031

PAPER Watanabe M, Nakamura Y, Yoshiyama Y, Kagimura T, Kawaguchi H, Matsuzawa H, Tachibana Y, Nishimura K, Kubota N, Kobayashi M, Saito T, Tamura K, Sato T, Takahashi M, Japanese Society of Scaling Keys of Evaluation Techniques for CNS Disorders Heterogeneity (SKETCH) study group, Homma A

Analyses of natural courses of Japanese patients with Alzheimer's disease using placebo data from placebo-controlled, randomized clinical trials: Japanese Study on the Estimation of Clinical course of Alzheimer's disease.

Alzheimers Dement (N Y). 2019;5:398-408. Epub 2019 Aug 29 PubMed: 31517028